Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-28 @ 3:28 PM
Study NCT ID:
NCT05315557
Status:
UNKNOWN
Last Update Posted:
2022-04-07
First Post:
2022-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
Sponsor:
Institute of Liver and Biliary Sciences, India
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-07
First Submit QC Date:
None
Study First Post Date:
2022-04-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-30
Last Update Post Date:
2022-04-07
Last Update Post Date Type:
ACTUAL